SCHEMBL12265015

SCHEMBL12265015

c1ccc(-c2nc(-n3c4ccccc4c4c5c(c6ccccc6n5-c5ccc6ccccc6c5)c5c6ccccc6n(-c6ccc7ccccc7c6)c5c43)cc(-n3c4ccccc4c4c5c(c6ccccc6n5-c5ccc6ccccc6c5)c5c6ccccc6n(-c6ccc7ccccc7c6)c5c43)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.36
MAPK10 P53779 6/20 0.36
MAPK9 P45984 5/20 0.36
HPGD P15428 1/20 0.34
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
RAB9A P51151 2/20 0.33
PMM2 O15305 1/20 0.33
MPI P34949 1/20 0.33
PHOSPHO1 Q8TCT1 1/20 0.33
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
HSD17B10 Q99714 3/20 0.32
MAPT P10636 2/20 0.32
TSHR P16473 2/20 0.32
MAPK1 P28482 2/20 0.32
KDM4E B2RXH2 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MEN1 O00255 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12265001 0.88 HTT (0.38) HTTMAPK10MAPK9HPGDALDH1A1
SCHEMBL17445372 0.85 MAPT (0.39) HTTMAPK10MAPK9HPGDALDH1A1
SCHEMBL21109023 0.83 KDM4E (0.46) MAPK10MAPK9HPGDALDH1A1SMN1; SMN2
SCHEMBL21108741 0.83 KDM4E (0.46) MAPK10MAPK9HPGDALDH1A1SMN1; SMN2
SCHEMBL21108813 0.83 KDM4E (0.46) MAPK10MAPK9HPGDALDH1A1SMN1; SMN2
SCHEMBL18996048 0.82 MAPK1 (0.41) HTTMAPK10MAPK9HPGDALDH1A1
SCHEMBL20998093 0.82 MAPK10 (0.36) MAPK10MAPK9HPGDALDH1A1SMN1; SMN2
SCHEMBL14013690 0.82 ALDH1A1 (0.41) MAPK10MAPK9HPGDALDH1A1SMN1; SMN2
SCHEMBL12264986 0.81 KDM4E (0.39) HTTMAPK10MAPK9HPGDALDH1A1
SCHEMBL21108815 0.80 KDM4E (0.48) MAPK10MAPK9HPGDALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8013330-B2 Compound for organic electroluminescent device and organic electroluminescent device NIPPON STEEL CHEMICAL CO., LTD (JP) 2011-09-06 US disclosed
US-8013330-B2 Compound for organic electroluminescent device and organic electroluminescent device NIPPON STEEL CHEMICAL CO., LTD (JP) 2011-09-06 US disclosed
US-8008657-B2 Compound for organic electroluminescent device and organic electroluminescent device NIPPON STEEL CHEMICAL CO., LTD. (JP) 2011-08-30 US disclosed
US-8008657-B2 Compound for organic electroluminescent device and organic electroluminescent device NIPPON STEEL CHEMICAL CO., LTD. (JP) 2011-08-30 US disclosed
US-20100148161-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2010-06-17 US disclosed
US-20100148161-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2010-06-17 US disclosed
US-20100148162-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2010-06-17 US disclosed
US-20100148162-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100148162-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE WEE1, EML4, ELOC HTT 3224/4885MAPK10 2731/4885MAPK9 1144/4885
US-20100148161-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE ELOC, ICMT, LAGE3 HTT 3107/4885MAPK10 3111/4885MAPK9 1365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.